A retrospective study [16] including 296 HER2-positive breast cancer patients who underwent NACT showed that the use of radiation-free MRI can effectively forecast pCR after NACT in HER2-positive breast cancer, particularly in the hormone receptor (HR)-negative subtype. The gene discussed is NR4A1; the disease is breast cancer.